Long Covid is affecting women more than men, national survey finds

Long Covid is affecting women more than men, national survey finds


A woman receives a dose of a vaccine against the coronavirus disease (COVID-19) at a sport stadium during the coronavirus disease pandemic, in Vina del Mar, Chile, April 22, 2021.

Rodrigo Garrido | Reuters

Long Covid is more common among women than men, according to federal data.

More than 17% of women have had long Covid at some point during the pandemic, compared with 11% of men, according to data from U.S. Census Bureau and National Center for Health Statistics published this month.

Long Covid was defined as experiencing symptoms for three months or more after infection. The most recent data was collected through an online survey of more than 41,000 adults during the two weeks ending Oct. 17.

Women were also more likely to suffer from more severe long Covid, the survey found. Some 2.4% of all women had symptoms that significantly limited their normal activities, compared with 1.3% of men, according to the data.

Overall, more than 14% of U.S. adults had long Covid at some point during the pandemic, the survey found. Seven percent of U.S. adults currently have long Covid, according to the data.

If those figures held true for the general population, 36 million adults could have had long Covid at some point during the pandemic, while 18 million could currently be dealing with it.

About 2% of adults in the U.S. have suffered from more severe long Covid symptoms that significantly limited their daily activities, according to the data. That would be equivalent to more than 5 million people in the general U.S. adult population.

The Brookings Institution, in a separate analysis, found that as many as 4 million people in the U.S. are unable to work due to long Covid.

CNBC Health & Science

Read CNBC’s latest global health coverage:

  • Long Covid is affecting women more than men, federal survey finds
  • Omicron subvariants resistant to key antibody treatments are increasing every week in the U.S.
  • FDA says two studies showing omicron boosters weren’t much better than old Covid shots were too small to come to any conclusions
  • New Covid boosters aren’t better than old shots at neutralizing omicron BA.5, early studies find
  • Omicron subvariants are resistant to key antibody treatments, putting people with weak immune systems at risk of Covid
  • Dr. Jha: A ‘tripledemic’ is about to hit the U.S., but ‘we’re not powerless against it’
  • The types of Covid symptoms you get depend on the vaccines you’ve received, new data says
  • People who caught mild Covid had increased risk of blood clots, British study finds
  • How concerned should you be about Covid-19 ‘Scrabble’ variants? Here’s what we know so far
  • Supreme Court Justice Samuel Alito told Ted Kennedy the legal basis ensuring abortion rights was ‘settled’ law in 2005, new book reveals
  • Ivermectin — a drug once touted as a Covid treatment by conservatives — doesn’t improve recovery much, clinical trial finds
  • It’s time to stop saying ‘fully vaccinated’ for Covid, experts say—here’s why
  • Millions at risk of losing health insurance if U.S. ends Covid public health emergency in January
  • FDA panel recommends revoking the approval of controversial drug intended to prevent premature birth
  • People of color face higher risk of flu hospitalization as U.S. faces potentially severe season, CDC says
  • White House Covid czar calls on seniors to get omicron booster now

Long Covid presents a wide array symptoms that vary from mild to debilitating and affect multiple organ systems. Some of the most commonly reported symptoms include poor memory or brain fog, fatigue, shortness of breath and loss of smell, according to a recent study published in Journal of the American Medical Association.

The JAMA study also found that long Covid was more common among women. Nearly 18% of Covid survivors who had symptoms for more than two months were women, while 10% were men.

The dominant Covid variant and vaccination status may also play roles in how likely people are to get long Covid.

Nearly 60% people who developed long Covid were infected with the original virus strain that emerged in China, while more than 17% caught the delta variant and more than 10% had omicron, according to the JAMA study.

The study found that 87% of those who had long Covid were unvaccinated.

“There may be differences in these strains and how likely they are to cause long Covid that could teach us something about why this happens,” said Dr. Roy Perlis, the lead author on the study and co-director of the Center for Quantitative Health at Massachusetts General Hospital.

The JAMA study, which published last week, looked at more than 16,000 adults who tested positive for Covid. The data was collected from February 2021 through July 2022 from a national online survey conducted every six weeks called the Covid States Project.

Scientists do not understand the underlying cause of long Covid yet, though there’s a growing consensus that it is likely several distinct conditions and not a single disease. The National Institutes of Health is enrolling a massive study, called Recover, to precisely define the different types of long Covid, identify risk factors and develop tests and treatments.



Source

Danish weight loss drug maker outlines ambitious 2030 strategy, ramping up pressure on Novo, Lilly
Health

Danish weight loss drug maker outlines ambitious 2030 strategy, ramping up pressure on Novo, Lilly

Celsopupo | Istock | Getty Images Zealand Pharma on Thursday outlined an ambitious five-year strategy for its anti-obesity portfolio Thursday, spotlighting how growing competition from smaller players is tightening the race for market leaders Novo Nordisk and Eli Lilly as more of these medicines near market entry. The new strategy, “Metabolic Frontier 2030,” comes as Zealand […]

Read More
Eli Lilly to build  billion manufacturing plant in Alabama to help make upcoming obesity pill, other drugs
Health

Eli Lilly to build $6 billion manufacturing plant in Alabama to help make upcoming obesity pill, other drugs

Eli Lilly CEO David A. Ricks speaks at a press conference at Generation Park in Houston, Monday, Sept. 23, 2025. The company announced plans for a $6.5 billion biomanufacturing plant in north Houston. (Raquel Natalicchio/Houston Chronicle via Getty Images) Raquel Natalicchio | Houston Chronicle | Getty Images Eli Lilly on Tuesday said it will spend […]

Read More
A biotech stock for investors scared to invest in the risky industry
Health

A biotech stock for investors scared to invest in the risky industry

Citigroup thinks investors should consider Ligand Pharmaceuticals for a more conservative bet on the biotech industry. The bank initiated the biotech stock at a buy rating and price target of $270, implying upside of 46% from Ligand’s Monday closing price of $184.67. Shares have soared nearly 79% this year. LGND YTD mountain LGND YTD chart […]

Read More